Good news this week for patients living with cancer and other chronic diseases with further specialised drugs being included on the Pharmaceutical Benefits Scheme (PBS). The savings for patients, which commenced this month are substantial.
Patients needing to use section 100 Highly Specialised Drugs and section 100 injectable and infusible chemotherapy medicines will now be covered under the PBS. This means publically hospitalised patients can potentially save as much as $1,400 per year.
Patients with cancer and HIV, with organ and tissue transplants, schizophrenia, hepatitis, Crohn’s disease and cystic fibrosis are set to benefit most from these additions to the PBS. Patients with psoriatic and rheumatoid arthritis, or severe allergic asthma and rare diseases, particularly children, will also benefit from their respective forms of treatment being added to the Scheme.
Non-admitted patients, outpatients or day patients, inpatients on discharge from public hospitals and privately referred non-admitted patients in NSW public hospitals will all benefit from the changes, and prescriptions can be lodged at public hospital pharmacies, community pharmacies or any pharmacy used by the NSW public hospital oncology clinics.
You can find out more about the changes at www.health.nsw.gov.au/pharmaceutical.